SK279968B6 - Imunogénny prostriedok, sekvencia rekombinantnej d - Google Patents

Imunogénny prostriedok, sekvencia rekombinantnej d Download PDF

Info

Publication number
SK279968B6
SK279968B6 SK1341-95A SK134195A SK279968B6 SK 279968 B6 SK279968 B6 SK 279968B6 SK 134195 A SK134195 A SK 134195A SK 279968 B6 SK279968 B6 SK 279968B6
Authority
SK
Slovakia
Prior art keywords
ospc
antigens
lyme disease
strains
immunogenic composition
Prior art date
Application number
SK1341-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK134195A3 (en
Inventor
Ian Livey
Brian Crowe
Friedrich Dorner
Original Assignee
Immuno Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Aktiengesellschaft filed Critical Immuno Aktiengesellschaft
Publication of SK134195A3 publication Critical patent/SK134195A3/sk
Publication of SK279968B6 publication Critical patent/SK279968B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK1341-95A 1993-04-29 1994-04-29 Imunogénny prostriedok, sekvencia rekombinantnej d SK279968B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5386393A 1993-04-29 1993-04-29
PCT/EP1994/001365 WO1994025596A2 (en) 1993-04-29 1994-04-29 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS

Publications (2)

Publication Number Publication Date
SK134195A3 SK134195A3 (en) 1996-05-08
SK279968B6 true SK279968B6 (sk) 1999-06-11

Family

ID=21987063

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1341-95A SK279968B6 (sk) 1993-04-29 1994-04-29 Imunogénny prostriedok, sekvencia rekombinantnej d

Country Status (16)

Country Link
EP (1) EP0701612B1 (cs)
JP (1) JPH08509371A (cs)
AT (1) ATE162550T1 (cs)
AU (1) AU683260B2 (cs)
CA (1) CA2161534A1 (cs)
CZ (1) CZ289212B6 (cs)
DE (1) DE69408135T2 (cs)
DK (1) DK0701612T3 (cs)
ES (1) ES2114687T3 (cs)
FI (1) FI955150A7 (cs)
HR (1) HRP940279B1 (cs)
HU (1) HU217024B (cs)
NO (1) NO954318L (cs)
PL (1) PL178775B1 (cs)
SK (1) SK279968B6 (cs)
WO (1) WO1994025596A2 (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5915049A (en) * 1992-02-25 1999-06-22 Pfu Limited Binarization system for an image scanner
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
CA2253374C (en) * 1996-05-02 2004-07-20 Marianne Jartved Mathiesen Novel osp-c derived peptide fragments
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
DE19629543C2 (de) * 1996-07-22 1999-02-11 Immuno Ag Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
WO2000006745A1 (en) * 1998-07-31 2000-02-10 Gundersen Lutheran Medical Foundation, Inc. Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
EP1194559B1 (en) * 1999-06-18 2006-09-20 Research Foundation Of State University Of New York Groups of borrelia burgdorferi that cause lyme disease in humans
DE60131982T2 (de) 2000-08-18 2008-12-11 Brookhaven Science Associates Llc Veränderte borrelia burgdorferi ospa
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
CA2631733C (en) * 2005-11-29 2017-08-01 Virginia Commonwealth University Polyvalent chimeric ospc vaccinogen and diagnostic antigen
JP5177824B2 (ja) * 2006-11-03 2013-04-10 シェーリング−プラウ・リミテッド イヌのライム病のワクチン
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
WO2025015077A1 (en) * 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease

Also Published As

Publication number Publication date
CZ289212B6 (cs) 2001-12-12
DK0701612T3 (da) 1998-09-21
HU217024B (hu) 1999-11-29
SK134195A3 (en) 1996-05-08
CA2161534A1 (en) 1994-11-10
AU683260B2 (en) 1997-11-06
AU6722994A (en) 1994-11-21
ATE162550T1 (de) 1998-02-15
DE69408135D1 (de) 1998-02-26
FI955150L (fi) 1995-12-28
HUT72923A (en) 1996-06-28
DE69408135T2 (de) 1998-06-10
PL178775B1 (pl) 2000-06-30
WO1994025596A2 (en) 1994-11-10
CZ283995A3 (en) 1996-03-13
NO954318D0 (no) 1995-10-27
HU9502002D0 (en) 1995-08-28
JPH08509371A (ja) 1996-10-08
PL311301A1 (en) 1996-02-05
EP0701612B1 (en) 1998-01-21
FI955150A0 (fi) 1995-10-27
ES2114687T3 (es) 1998-06-01
NO954318L (no) 1995-12-29
EP0701612A1 (en) 1996-03-20
WO1994025596A3 (en) 1994-12-22
FI955150A7 (fi) 1995-12-28
HRP940279A2 (en) 1997-10-31
HRP940279B1 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
US5747294A (en) Compositions and methods for the prevention and diagnosis of lyme disease
EP0650527B1 (en) Improvement in borrelia burgdorferi diagnosis and prophylaxis
US6486130B1 (en) Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
SK279968B6 (sk) Imunogénny prostriedok, sekvencia rekombinantnej d
CA2294701C (en) Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
CZ280743B6 (cs) Imunogen proti lymské boreliose savců
EP1123403A1 (en) OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF
Layh-Schmitt et al. Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon
US5777095A (en) Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
US5324630A (en) Methods and compositions for diagnosing lyme disease
CA2077434C (en) Antigenic proteins of borrelia burgdorferi
US7169393B2 (en) Antigenic peptide fragments of VapA protein, and uses thereof
AU712882B2 (en) Leptospira membrane proteins
AU704821B2 (en) New 17-KDA brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
WO1994020536A1 (en) Methods, compositions, and kits for diagnosing lyme disease
AU645078C (en) Antigenic proteins of (borrelia burgdorferi)